Mercer Global Advisors
BSX icon

Mercer Global Advisors’s Boston Scientific BSX Stock Holding History

Mercer Global Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.82M Buy
206,605
+10,654
+5% +$579K 0.01% 618
2026
Q1 		$12.3M Buy
195,951
+92,975
+90% +$7.44M 0.02% 443
2025
Q4 		$9.84M Sell
102,976
-2,167
-2% -$212K 0.02% 496
2025
Q3 		$10.3M Buy
105,143
+4,051
+4% +$420K 0.02% 457
2025
Q2 		$10.9M Buy
101,092
+11,334
+13% +$1.15M 0.02% 373
2025
Q1 		$9.05M Buy
89,758
+15,883
+21% +$1.6M 0.02% 386
2024
Q4 		$6.6M Sell
73,875
-9,459
-11% -$833K 0.02% 466
2024
Q3 		$7.01M Buy
83,334
+24,365
+41% +$1.92M 0.02% 411
2024
Q2 		$4.55M Buy
58,969
+888
+2% +$65K 0.01% 477
2024
Q1 		$3.98M Buy
58,081
+9,280
+19% +$597K 0.01% 526
2023
Q4 		$2.82M Buy
48,801
+955
+2% +$51K 0.01% 629
2023
Q3 		$2.53M Buy
47,846
+15,588
+48% +$818K 0.01% 628
2023
Q2 		$1.75M Buy
32,258
+4,616
+17% +$241K 0.01% 769
2023
Q1 		$1.38M Sell
27,642
-1,765
-6% -$83.2K 0.01% 797
2022
Q4 		$1.36M Buy
29,407
+3,767
+15% +$163K 0.01% 799
2022
Q3 		$993K Buy
25,640
+751
+3% +$30.1K 0.01% 845
2022
Q2 		$927K Sell
24,889
-240
-1% -$9.77K 0.01% 879
2022
Q1 		$1.11M Sell
25,129
-654
-3% -$28.3K 0.01% 853
2021
Q4 		$1.09M Buy
25,783
+1,967
+8% +$82.7K 0.01% 845
2021
Q3 		$1.03M Buy
23,816
+5,569
+31% +$246K 0.01% 843
2021
Q2 		$780K Buy
18,247
+2,207
+14% +$92.9K 0.01% 949
2021
Q1 		$620K Buy
16,040
+5,077
+46% +$192K 0.01% 986
2020
Q4 		$394K Sell
10,963
-472
-4% -$17K ﹤0.01% 962
2020
Q3 		$437K Buy
11,435
+467
+4% +$18K 0.01% 822
2020
Q2 		$385K Sell
10,968
-181
-2% -$6.52K 0.01% 770
2020
Q1 		$364K Buy
11,149
+642
+6% +$25.1K 0.01% 752
2019
Q4 		$475K Sell
10,507
-229
-2% -$9.58K 0.01% 752
2019
Q3 		$436K Buy
10,736
+548
+5% +$23.2K 0.01% 742
2019
Q2 		$438K Sell
10,188
-100
-1% -$3.85K 0.01% 734
2019
Q1 		$395K Buy
+10,288
New +$393K 0.01% 723

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Mercer Global Advisors's BSX Position: Q2 2026 in Review

Mercer Global Advisors increased its Boston Scientific (BSX) stake by 5.4% in Q2 2026, buying an estimated $579K and bringing the position to 206,605 shares worth $8.82M. The position accounts for 0.01% of the portfolio, ranked #618.

Mercer Global Advisors first reported a position in BSX in Q1 2019 and has held it in 30 quarters since. The position peaked at $12.3M in Q1 2026. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Mercer Global Advisors held 206,605 shares of Boston Scientific worth $8.82M as of Q2 2026.
  • Mercer Global Advisors bought 10,654 Boston Scientific shares in Q2 2026, an estimated $579K.
  • Boston Scientific made up 0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #618 holding.
  • Mercer Global Advisors first reported a position in Boston Scientific in Q1 2019 and has held it in 30 quarters since.
  • Mercer Global Advisors's Boston Scientific position peaked at $12.3M in Q1 2026.
  • 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.